Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer.

about

Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.

P2860

Q42288648-CB672597-77EC-40E4-A72E-26F3B06B9A61

P2860

Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer.

Item

http://www.wikidata.org/entity/Q53641063

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Phase I clinical and pharmacok ...... metastatic colorectal cancer.

@en

Phase I clinical and pharmacok ...... metastatic colorectal cancer.

@nl

type

Item

label

Phase I clinical and pharmacok ...... metastatic colorectal cancer.

@en

Phase I clinical and pharmacok ...... metastatic colorectal cancer.

@nl

prefLabel

Phase I clinical and pharmacok ...... metastatic colorectal cancer.

@en

Phase I clinical and pharmacok ...... metastatic colorectal cancer.

@nl

P1476

Phase I clinical and pharmacok ...... metastatic colorectal cancer.

@en

P2093

Hiroyuki Narahara

http://www.w3.org/2001/XMLSchema#string

Ichinosuke Hyodo

http://www.w3.org/2001/XMLSchema#string

Kunihiro Yoshisue

http://www.w3.org/2001/XMLSchema#string

Naotoshi Sugimoto

http://www.w3.org/2001/XMLSchema#string

Narikazu Boku

http://www.w3.org/2001/XMLSchema#string

Takayuki Yoshino

http://www.w3.org/2001/XMLSchema#string

Tomohiro Nishina

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LV

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial

Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer.

P2888

s00280-016-3212-6

P304

107-116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-016-3212-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27933371

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer.

about

P2860

P2860

Phase I clinical and pharmacokinetic study of S-1 plus oral leucovorin in patients with metastatic colorectal cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921